Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

octapharma ag, switzerland - human immunoglobulin proteins - solution for infusion - 100 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

octapharma ag, switzerland - human immunoglobulin proteins - solution for infusion - 100 mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

octapharma australia pty ltd - human immunoglobulin g, quantity: 1 g - injection, intravenous infusion - excipient ingredients: human immunoglobulin a; water for injections; glycine - replacement therapy in:,? primary immunodeficiency diseases.,? myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent bacterial infections.,? symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,immunomodulation in:,? idiopathic thrombocytopenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count.,? guillain barr? syndrome.,? kawasaki disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

octapharma australia pty ltd - human immunoglobulin g, quantity: 10 g - injection, intravenous infusion - excipient ingredients: human immunoglobulin a; glycine; water for injections - replacement therapy in:,? primary immunodeficiency diseases.,? myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent bacterial infections.,? symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,immunomodulation in:,? idiopathic thrombocytopenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count.,? guillain barr? syndrome.,? kawasaki disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

octapharma australia pty ltd - human immunoglobulin g, quantity: 5 g - injection, intravenous infusion - excipient ingredients: human immunoglobulin a; water for injections; glycine - replacement therapy in:,? primary immunodeficiency diseases.,? myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent bacterial infections.,? symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,immunomodulation in:,? idiopathic thrombocytopenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count.,? guillain barr? syndrome.,? kawasaki disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

octapharma australia pty ltd - human immunoglobulin g, quantity: 20 g - injection, intravenous infusion - excipient ingredients: glycine; water for injections; human immunoglobulin a - replacement therapy in:,? primary immunodeficiency diseases.,? myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent bacterial infections.,? symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,immunomodulation in:,? idiopathic thrombocytopenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count.,? guillain barr? syndrome.,? kawasaki disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

octapharma australia pty ltd - human immunoglobulin g, quantity: 2.5 g - injection, intravenous infusion - excipient ingredients: human immunoglobulin a; glycine; water for injections - replacement therapy in:,? primary immunodeficiency diseases.,? myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent bacterial infections.,? symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,immunomodulation in:,? idiopathic thrombocytopenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count.,? guillain barr? syndrome.,? kawasaki disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

octapharma australia pty ltd - human immunoglobulin g, quantity: 30 g - injection, intravenous infusion - excipient ingredients: human immunoglobulin a; water for injections; glycine - replacement therapy in:,? primary immunodeficiency diseases.,? myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent bacterial infections.,? symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,immunomodulation in:,? idiopathic thrombocytopenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count.,? guillain barr? syndrome.,? kawasaki disease.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

octapharma ltd - normal immunoglobulin human - solution for infusion - 100mg/1ml